Clinical trial
Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in…
NCT01182441 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT01182441 |
|---|---|
| Title | Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy |
| Official title | Prospective Randomized Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation (AF) Versus Long Term Warfarin Therapy |
| Acronym | PREVAIL |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation, Stroke |
| Intervention type | Device, Drug |
| Interventions | WATCHMAN Device, Warfarin |
| Enrollment | 407 |
| Start date | Nov 1, 2010 |
| Primary completion | Jan 1, 2013 |
| Completion | Nov 1, 2017 |
| First posted | Aug 16, 2010 |
| Last update posted | Jul 26, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: